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OBJECTIVE — RisksofdiabetesandcardiovasculardiseaseareelevatedworldwideinIndian
Asians. However, risks of other diabetes-related complications, i.e., foot ulceration and ampu-
tation,alsowithavascularbasis,aresubstantiallylowerinAsiansthaninwhiteEuropeansinthe
U.K., possibly due to less neuropathy. We therefore compared signs, symptoms, and objective
quantitative measures of diabetic neuropathy and their risk factors in Indian Asians and
Europeans.
RESEARCH DESIGN AND METHODS — This was a cross-sectional study of a popu-
lation-based sample of age- and sex-matched adults with type 2 diabetes of European (95 male
and 85 female) and Asian (96 male and 84 female) descent in the U.K. Patients were assessed for
neuropathic symptoms, signs, nerve conduction, autonomic function, and quantitative sensory
testing. Peripheral vascular function and other potential risk factors for neuropathy were
measured.
RESULTS — Mean nerve conduction velocity Z scores were better in Asians (mean  SD
0.07  0.62) than in Europeans (0.11  0.60; P  0.007) and were explained by the
shorter height, fewer pack-years smoked, and higher transcutaneous oxygen levels (TCpO2)
in Indian Asians (P value for ethnic comparison attenuated to 0.2). Small ﬁber neuropathy
was less prevalent in Indian Asians compared with Europeans (odds ratio 0.58 [95% CI
0.37–0.93];P  0.02)andwasprimarilyaccountedforbybetterTCpO2 (0.70[0.40–1.21];
P  0.2).
CONCLUSIONS — Asians with diabetes have substantially less large and small ﬁber neu-
ropathy than Europeans, despite comparable traditional risk factors. Independent from smok-
ing, the lower risk of neuropathy in Asians is due to better skin microvascularization and may
help explain the substantially reduced Asian foot ulcer risk.
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P
eople of Indian Asian descent
worldwide have one of the highest
risks of type 2 diabetes; in the U.K.,
this is four times more prevalent than in
the general population (1). Most studies
indicate that risks of cardiovascular dis-
ease(CVD)inIndianAsianswithdiabetes
aregreaterthanthatinEuropeans,reﬂect-
ing their overall greater predisposition to
CVD(2,3).Althoughmanydiabetescom-
plications have a vascular basis, we and
others have shown, paradoxically, that
risks of both foot ulceration and amputa-
tionaresubstantiallylower(threefoldand
fourfold, respectively) in Indian Asians
compared with Europeans (4,5) and that
lower rates of peripheral neuropathy in
Indian Asians may, to a large extent, ac-
count for this protection. To date, how-
ever, neuropathy assessments have been
crude, subjective, and not comprehen-
sive, and explanations for ethnic differ-
ences have not been sought.
This study was designed to compare
andaccountfordifferencesinneuropathy
between Indian Asians and Europeans
with type 2 diabetes. We hypothesized
that Indian Asians would have preserved
large and small nerve function, using ob-
jective criteria, compared with Europe-
ans, and that this would only be partly
explained by differences in conventional
risk factors.
RESEARCH DESIGN AND
METHODS— This was a cross-
sectional study of a randomly selected
population-based sample of people with
type 2 diabetes of European and Indian
Asian descent drawn from primary care
registers in Manchester, U.K.
Type 2 diabetes was deﬁned as a di-
agnosis made between age 30 and 39
years without insulin until at least 2 years
after diagnosis or a diagnosis at age 40
years and above regardless of initial treat-
ment. Because the mean age of diabetes
diagnosis is generally younger in Indian
Asians than in Europeans, broadening in-
clusion criteria for these individuals re-
duced the risk of a biased sample (5). A
5-year age stratum, ethnicity- and sex-
matched sample of Indian Asians and Eu-
ropeans with known type 2 diabetes was
drawnfromeightprimarycareregistersin
Central Manchester, all of which partici-
pate in ethnicity monitoring. Exclusion
criteria were lower limb amputation, psy-
chiatricdisorder,knownHIVpositivityor
hepatitis carrier, terminal illness, or in-
abilitytounderstandthestudyorprovide
informed consent. We required 360 peo-
ple with diabetes (180 from each ethnic
group). To achieve this, a total sample of
682 eligible patients was selected for in-
vitation (52% Indian Asian and 51%
male; mean  SD age 59  11 years). Of
this sample, 360 subjects (53% response
rate) gave written consent to participate
(50% Indian Asian and 47% male; age
58  10 years). Differences between re-
sponders and nonresponders for age, sex,
and ethnicity were not signiﬁcant. This
studywasapprovedbyNorthManchester
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Assessments
Consenting participants fasted at the
Manchester Royal Inﬁrmary. A question-
naire was completed to obtain demo-
graphic data, medical history including
drugs, and lifestyle factors. Ethnicity was
checked, and country of birth was re-
corded(allIndianAsianparticipantswere
ﬁrst-generation migrants). Trained per-
sonnel performed all measurements with
standardized procedures and equipment
according to existing protocols. We mea-
sured height, weight, and waist and hip
circumference by a single measurement.
Fasting blood samples were taken
and sent to central laboratories for mea-
surement of A1C, fasting plasma glucose,
total cholesterol, HDL cholesterol, trig-
lycerides, and serum -glutamyltrans-
ferase (marker of alcohol consumption).
Fasting serum insulin was measured us-
ing a sensitive in-house radioimmunoas-
say as described previously (6).
Clinical complications of diabetes
Retinopathy and nephropathy were de-
ﬁned as a history of physician-diagnosed
disease.Serumandearlymorningurinary
creatinine were measured on a Roche
MODULARPUnitusingtheJaffemethod.
Urinary albumin was measured on a
Beckman Array analyzer using their
nephelometric assay. The urinary albu-
min-to-creatinine ratio was calculated.
CVD was deﬁned as either a physi-
cian-diagnosedmyocardialinfarction,an-
gina, coronary artery bypass graft or
stroke, or a positive response to the Rose
Angina Questionnaire (7). Peripheral ar-
terial disease was deﬁned as previous his-
tory of physician-diagnosed claudication
conﬁrmed by lower limb arteriogram or a
positive response to the Edinburgh Clau-
dication Questionnaire (8).
Assessment and deﬁnition of
neuropathy
Clinical symptoms and signs of neu-
ropathy. Symptoms of muscle weakness,
sensation, and autonomic neuropathy
were determined from the Neuropathy
Symptoms and Change (NSC) validated
questionnaire(9).Signswereassessedus-
ing the modiﬁed Neuropathy Disability
Score (NDS), comprising pinprick, vibra-
tion,temperaturesensation,andanklere-
ﬂexes. An NDS of 6 indicated clinical
neuropathy (10).
Large ﬁber neuropathy. Electrophysio-
logical assessments of peroneal, tibial,
and ulnar nerves (motor nerve conduc-
tion velocity [NCV] and maximum M-
wave amplitude) and sural and radial
nerves (NCV and amplitude) were per-
formedusingaDantecCounterpointelec-
tromyograph system with surface
electrodes (skin temperature 32°C).
These assessments provide multiple, sim-
ilar,markersofperipheralnervefunction;
therefore, we constructed Z scores. For
each individual, every NCV value was ex-
pressed as a Z score, i.e., (value in the
individual minus mean value in the over-
all study population) divided by the SD.
AnaverageNCVZscorewascalculatedas
[(Z score sural NCV)  (Z score peroneal
below ﬁbular head NCV)  (Z score
peroneal knee NCV)  (Z score tibial
NCV)  (Z score radial NCV)  (Z score
ulnar NCV)]/6. Thus, the more positive
the result, the better the nerve function.
The response amplitude Z score was cal-
culated similarly.
Vibrationperceptionthreshold(VPT)
wasassessedattherightandleftgreattoes
in duplicate using a calibrated Neuroth-
esiometer (Horwell; Scientiﬁc Laboratory
Supplies, Nottingham, U.K.) (11). Read-
ings were averaged for analyses.
Small ﬁber neuropathy. Cooling detec-
tion thresholds (CDTs), heat pain mini-
mal threshold (HP-VAS0.5), and heat
painintermediatethreshold(HP-VAS5.0)
were evaluated on the dorsum of the left
footusingaCASEIVsystem(WRMedical
Electronics, Stillwater, MN) (12). For
thermal thresholds 95th percentile of
the CASE IV normality range was consid-
ered abnormal.
Autonomic function was assessed by
1) change in resting heart rate in response
to two separate cycles of deep breathing
(HRDB) using a CASE IV system (5th
percentileoftheCASEIVnormalityrange
was considered abnormal) (12) and 2)
changeinsystolicbloodpressurefromthe
lying position to the standing position,
using a Critikon Dinamap 8100T plus
adult Dura-Cuf.
Algorithm for small ﬁber neuropathy
Small ﬁber neuropathy was classiﬁed us-
ing an algorithm incorporating the CASE
IV normality range for HRDB, CDT, HP-
VAS0.5, and HP-VAS5.0 (12). The sever-
ity of small ﬁber dysfunction was
stratiﬁed as normal (all tests normal),
mild (one abnormal test), moderate (two
abnormal tests), and severe (3 abnor-
maltests).Smallﬁberneuropathywasde-
ﬁned as the presence of mild, moderate,
or severe dysfunction.
Vascular function tests
The ankle-brachial pressure index (ABPI)
was determined using a Multi Dopplex II
ultrasound machine (Huntleigh Diagnos-
tics) and sphygmomanometer (Speidel &
Keller). Duplicate blood pressure read-
ings were averaged for each limb, and
ABPI was averaged for the right and left
sides combined. Abnormal ABPI was de-
ﬁnedas0.85(13).Transcutaneouspar-
tial pressure of oxygen (TCpO2) was
determined on the left foot dorsal surface
using a transcutaneous monitor and oxy-
gensensor(NovametrixMedicalSystems,
Wallingford, CT) (14). The patient was
semirecumbent, and foot skin tempera-
ture was maintained at 32°C. The cali-
brated TCpO2 sensor heated and
maintained skin temperature at 44°C.
This produced a local maximal vasodila-
tion to increase the permeability of the
skintooxygen.Measurementsweretaken
after 20 min of stabilization.
Statistical analysis
NCVwasselectedastheprimaryoutcome
of interest, as it is an early marker of dis-
ease and measured objectively. We esti-
mated that 360 patients (180 in each
ethnic group) would be sufﬁcient, with
85% power to detect a difference in NCV
of at least one-third of a SD, at the 5%
signiﬁcance level, making allowances for
missing data.
Measures of neuropathy were com-
pared between the ethnic groups as con-
tinuous variables, using simple means.
Normally distributed data were tested us-
ing a Student t test; non-normally distrib-
uted data were log transformed before
analysis or the Mann-Whitney test was
used. Multivariate linear regression mod-
els using ANOVA were constructed to ex-
plore the role of potential confounders
including glycemic control, height,
smoking, and hypertension and deter-
mine which factors could account for any
ethnic differences in measures of neurop-
athy. Categorical variables were com-
pared as simple proportions in the ﬁrst
instance,usingthe
2testforsigniﬁcance.
Logistic regression models were con-
structed to calculate odds ratios (ORs)
andadjustforimportantconfounders.In-
teractions with ethnicity were also tested.
RESULTS— We studied 360 type 2
diabetic patients (Table 1). Indian Asians
(n  180) comprised 116 subjects origi-
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from India (14.4%), 31 subjects from
Bangladesh (17.2%), and 7 subjects clas-
siﬁed as Indian Asian–other (3.9%). The
white European group (n  180) com-
prised 157 subjects who were white Brit-
ish (87.2%) and 17 who were white Irish
(9.4%) with the remainder (n  6) being
white–other (3.3%).
Duration of diabetes was shorter in
Europeans than in Indian Asians (P 
0.01).Europeansweretallerwithahigher
BMI, greater smoking prevalence, and
higher alcohol intake (P  0.001). Signif-
icantly more Indian Asians were treated
with oral hypoglycemic agents, whereas
they were much less likely to be taking
lipid-lowering or antihypertensive thera-
pies (P  0.01).
Clinical signs and symptoms of
neuropathy
Neuropathy signs (NDS 6) were more
prevalent in Europeans (36 of 180, 20%)
than Indian Asians (27 of 178, 15%), al-
though this was not statistically signiﬁ-
cant(P0.2)(Fig.1A).Overallsymptom
reporting did not differ by ethnicity (total
mean NSC score for Europeans 2.2  2.2
andforIndianAsians2.22.1,P0.9);
however, Europeans reported greater loss
of peripheral sensation (0.29  0.77 vs.
0.13  0.45, P  0.018).
Large nerve ﬁber function
Indian Asians had higher mean values for
all motor and sensory NCVs and ampli-
tudesthanEuropeans(NCVandresponse
amplitude Z scores 0.07  0.62 and
0.08  0.69 [mean  SD] in Indian
Asians and 0.11  0.60 [P  0.007]
and 0.13  0.62 [P  0.003] in Euro-
peans (Fig. 1B). VPT did not differ by
ethnicity.
Small nerve ﬁber function
Cool detection threshold (Indian Asians
10.1  4.0 and Europeans 10.7  4.8;
P  0.2) or heat pain threshold (Indian
Asians 19.9  1.5 and Europeans 20.0 
1.7, P  0.4) did not differ by ethnicity.
HRDB was greater in Indian Asians
(10.8  7.4 bpm) versus Europeans
(8.5  5.3 bpm; P  0.002) (Fig. 1C),
whereas the postural fall in systolic blood
pressure did not differ. The overall prev-
alence of small ﬁber neuropathy was
signiﬁcantly lower in Indian Asians
(32%) than in Europeans (43%; P 
0.03) (Fig. 1A).
Ethnic differences in vascular
function
Peripheral vascular function was more fa-
vorable in Indian Asians than Europeans,
i.e., Indian Asians were less likely to re-
port claudication or have an abnormal
ABPI, and had higher TCpO2 levels (Ta-
ble 1). Adjustment for ethnic differences
in smoking status, height, lipid levels,
A1C,orABPIhadnoimpactontheethnic
difference in TCpO2 levels (data not
shown).
Table 1—Demographic and clinical characteristics of ethnic groups
Indian Asians White Europeans P value*
n 180 180
Sex (male/female) 95/85 96/84 0.9
Age (years) 57.4  9.9 59.1  9.7 0.09
Duration diabetes (years) 9.4  7.5 7.0  5.7 0.001
Height (m) 1.61  9.3 1.65  9.8 0.0001
Weight (kg) 77.2  14.8 93.3  19.3 0.0001
BMI (kg/m
2) 29.7  5.5 34.1  6.5 0.0001
Waist (cm)
Men 96.7  13.1 106.6  12.7 0.0001
Women 97.1  12.8 102.7  15.1 0.01
Hips (cm)
Men 99.6  8.1 105.4  8.7 0.0001
Women 103.1  11.3 111.0  15.6 0.0001
Waist-to-hip ratio
Men 0.97  0.09 1.01  0.07 0.0001
Women 0.94  0.08 0.92  0.08 0.2
Fasting plasma glucose (mmol/l) 7.7  2.2 8.0  2.3 0.2
A1C (%) 8.1  1.6 7.9  1.7 0.3
Total cholesterol (mmol/l) 4.3  1.0 4.7  1.1 0.004
HDL cholesterol (mmol/l) 1.3  0.3 1.3  0.4 0.7
Fasting triglycerides (mmol/l) 1.4 (1.1, 1.9) 1.7 (1.2, 2.4) 0.005
Insulin (mU/l) 17.1 (9.6, 27.0.1) 18.2 (11.5, 28.6) 0.44
-Glutamyltransferase (U/l) 35.7  34.4 58.7  56.0 0.0001
Creatinine (mol/l) 87.2  31.2 85.9  27.0 0.7
Urinary albumin-to-creatinine ratio 1.5 (0.7, 2.5) 1.4 (0.6, 3.0) 0.6
Retinopathy (%) 14 12 0.6
Nephropathy (%) 6 4 0.3
Hypertension (%) 54 74 0.0002
Myocardial infarction (%) 17 13 0.3
Angina (%) 23 17 0.2
Coronary artery bypass graft (%) 14 9 0.1
Resting heart rate (bpm) 76  14 75  13 0.8
Ankle systolic blood pressure (mmHg) 136  22 142  31 0.06
Brachial systolic blood pressure (mmHg) 123  17 127  17 0.02
ABPI 0.85 (%) 4.0 9.1 0.05
Lower limb vascular intervention (%) 3 9 0.03
Claudication (%) 7 15 0.01
TCpO2 (mmHg) 61  12 56  13 0.0001
Pack-years smoked (%) 0.0001
None 74 36
20 14 22
	20 11 42
Drink alcohol  once a week (%) 5 42 0.0001
Insulin (%) 19 23 0.4
Oral antidiabetic drugs (%) 87 76 0.007
Antihypertensive drugs (%) 61 77 0.001
Lipid-lowering drugs (%) 57 71 0.006
Other coronary heart disease drugs (%) 15 18 0.4
Data are % prevalence, means  SD, or geometric means (25th, 75th percentiles). *P value for ethnic
difference.
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in large nerve ﬁber function
Smoking had little impact in accounting
for the ethnic difference in peripheral
nerve large ﬁber function (NCV Z scores)
(Table 2). Height appeared to have the
greatest single impact, with a multivar-
iate model, including height, pack-
years smoked, and TCpO2 substantially
attenuating the ethnic difference in
nerve function, losing statistical signiﬁ-
cance (P  0.2). An analysis restricted
to never smokers showed that Indian
AsiansmaintainedgreaterNCVZ scores
than their European counterparts (0.13
[95% CI 0.025–0.24] versus 0.06
[0.23 to 0.10], P  0.05).
Explanations for ethnic differences
in small ﬁber neuropathy
The risk (OR) of small ﬁber neuropathy
was 0.61 (P  0.03) in Indian Asians ver-
sus Europeans (Table 3). Adjustment for
the lower smoking rates and shorter
height in Indian Asians did not apprecia-
bly alter this ethnic difference in risk, but
some attenuation was observed with ad-
justment for ABPI and for TCpO2. A mul-
tivariate model with all of these factors
attenuated the OR to 0.70 (P  0.2). The
impacts of ABPI (P  0.02) and TCpO2
(P  0.02) in this multivariate model
were statistically signiﬁcant and indepen-
dent of each other. As a sensitivity analy-
sis, we also compared small ﬁber
neuropathy in never smokers, and the
ethnic difference persisted (n  178):
31% in Indian Asians and 52% in Euro-
peans(P0.009).OnlyBMIappreciably
accounted for the ethnic difference in au-
tonomic small ﬁber function, i.e., HRDB
(10.4 vs. 9.1 bpm, P  0.08, in Indian
Asians vs. Europeans) (Table 3); height
alone had negligible impact.
CONCLUSIONS — We show, using
objective measurements, that both so-
matic and autonomic nerve function is
better preserved in Indian Asians than in
Europeans with diabetes. Healthier pe-
ripheral vascular function was the key
modiﬁable determinant of this protection
from neuropathy in Indian Asians with
independent contributions from low
smoking rates and shorter height.
Although others have reported favor-
able levels of neuropathy in Indian
Asians,thesereportsreliedlargelyonsub-
jective, crude measures of advanced neu-
ropathy, and explanations for ethnic
differences were not explored (4,5,15).
Indian Asians with newly diagnosed dia-
betes in the UK Prospective Diabetes
Study had lower rates of neuropathy than
Europeans (4 compared with 13%) diag-
nosed using the vibration sensation
threshold (15). However, individuals
with preexisting CVD were excluded,
and, as this is more common in Indian
Asians, may have biased the comparison.
In our previous large, population-based
studies, we also showed that the preva-
lence of neuropathy was signiﬁcantly
lower in Indian Asians than in Europeans
with diabetes (4,5), but again objective
measures were not used. Varying rates of
peripheral neuropathy from the Indian
subcontinent have been reported (3–
25%) (16,17), but because assessment
methodsvary,itisdifﬁculttocomparethese
rates directly with European samples.
Height is often cited as a key risk fac-
tor for neuropathy; it is therefore not sur-
prising that the shorter height of Indian
Asians contributes to their lower risk
(18). The additional signiﬁcant contribu-
tions from lower smoking rates plus fa-
vorable peripheral blood ﬂow indicators
(TCpO2 and ABPI) support the vascular
theory for neuropathy etiology (19). Oth-
ers report that both macrovascular (sys-
tolic blood pressure, conduit arterial
stiffening,andthickness)(20)andmicro-
vascular (reduced capillary blood ﬂow
due to endothelium-dependent and inde-
pendent mechanisms) (21) abnormalities
are key determinants of nerve ﬁber func-
Figure 1—Indexes of neuropathy by ethnicity: Indian Asians and Europeans. A: Neuropathy
prevalence (percent). B: Nerve conduction studies (Z scores) (mean  SE). C: Autonomic nerve
function(meanSD).*Signiﬁcantlydifferentbetweenthetwogroups,P0.05.**Signiﬁcantly
different between the two groups, P  0.01. SBP, systolic blood pressure.
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ties are strongly correlated in individuals
and populations. However, we show that
despite the anticipated greater macrovas-
cular burden, Indian Asians have sub-
stantially better TCpO2 (not wholly
explained by lower smoking rates), and
that this contributes to the favorable neu-
ropathy status. TCpO2, or tissue oxygen-
ation, in the lower limb is an indicator of
“upstream blood ﬂow” and can be af-
fected by large vessel occlusion and arte-
riole and/or capillary function (22). In
addition, we show that peripheral arterial
disease, as measured by ABPI, is lower in
IndianAsiansandmakesasigniﬁcantand
independent contribution to account for
ethnic differences in peripheral neuropa-
thy, comparable to TCpO2. Our TCpO2
data, therefore, more likely reﬂect mi-
crovessel (capillary and arteriole) func-
tion rather than large vessel ﬂow. These
ﬁndings suggest that microvascular ﬂow
may explain ethnic differences in the eti-
ology of neuropathy. The reason that
Asians have better microvascular func-
tion, despite poorer macrovascular func-
tion is, as yet, unclear.
Elsewhere, glycemia, triglycerides,
and insulin resistance have been linked
with clinical polyneuropathy in type 2
diabetes(23,24).However,wefoundthat
these factors had little effect on account-
ing for ethnic differences and were over-
whelmed by the impact of tissue
oxygenation,probablyindicatingthatthis
is a better downstream measure of the
composite of vascular insults.
The marked ethnic differences in ob-
jective nerve electrophysiological mea-
sures were largely not reﬂected in
reported neuropathic symptoms or elic-
ited signs. This may reﬂect the greater
sensitivity of electrophysiology, detecting
veryearlysignsofdisease,andthesubjec-
tivity of signs and symptoms. The latter
is particularly important in ethnic com-
parison studies, in which interpretation
and reporting may differ. Our ﬁndings
underline the importance of objective as-
sessments. Our study is large and repre-
sentative of the general population with
diabetes, as sampling was from primary
rather than hospital care, the former hav-
ing universal coverage. In addition, be-
cause health care is free at the point of
delivery, differences in access to health
care should not have inﬂuenced our ﬁnd-
ings. One limitation of this study is that it
is cross-sectional, whereas a longitudinal
assessment of neuropathy development
would substantiate our ﬁndings. A possi-
ble explanation for the lower prevalence
of neuropathy observed in Indian Asians
is that the elevated risk of premature car-
diovascular death had selected out Indian
Asians with current or high risk of subse-
quent neuropathy. However, selective
mortality cannot be the full explanation
because we estimate that premature CVD
mortality would have to be 3- to 4-fold
greater, rather than the observed 1.5- to
2-fold increase in younger Indian Asians
than Europeans, to account for the lower
neuropathy prevalence detected in our
study.
We therefore conclude that both pe-
ripheral and autonomic neuropathy are
lessprevalentinIndianAsiansthaninEu-
ropeans with type 2 diabetes. Further-
more, lower height, less smoking, and a
more favorable microcirculation, rather
thanconventionalriskfactorssuchasgly-
cemic control and hyperlipidemia, seem
to account independently for the Indian
Asian preservation of peripheral nerve
function. These data may explain why In-
dian Asians are protected against diabetic
footulceration,assensitivitytotraumavia
peripheral large ﬁber function and auto-
nomic neurogenic control of cutaneous
blood ﬂow are primary factors in the risk
of plantar tissue breakdown and delayed
wound healing (4,25).
Acknowledgments— This study was sup-
ported by Diabetes U.K.
Table2—Largenerveﬁberfunction(meanNCVZscoreforsural,peroneal,tibial,radial,and
ulnar nerves combined) with 95% CIs, by ethnicity
Adjustment factors Indian Asian European P value*
Unadjusted 0.07 (0.02 to 0.16) 0.11 (0.20 to 0.02) 0.007
Age  diabetes duration 0.09 (0.002 to 0.18) 0.13 (0.22 to 0.04) 0.001
Age  duration  height 0.04 (0.04 to 0.12) 0.08 (0.16 to 0.01) 0.06
Age  duration  pack-years
smoked 0.07 (0.03 to 0.16) 0.11 (0.20 to 0.01) 0.01
Age  duration  TCpO2 0.11 (0.02 to 0.20) 0.09 (0.18 to 0.001) 0.003
Age  duration  height 
pack-years smoked 
TCpO2 0.05 (0.04 to 0.14) 0.03 (0.12 to 0.06) 0.2
*P value for ethnic difference.
Table 3—Regression modeling: small ﬁber neuropathy by ethnicity
Risk of small ﬁber neuropathy in Indian Asians vs. Europeans with adjustment for covariates
Adjustment factors Odds ratio (95% CI) P value*
Unadjusted 0.61 (0.39–0.95) 0.03
Age  diabetes duration 0.58 (0.37–0.93) 0.02
Age  duration  pack-years smoked 0.58 (0.35–1.00) 0.04
Age  duration  pack-years smoked  height 0.61 (0.36–1.02) 0.06
Age  duration  pack-years smoked  ABPI 0.85 0.64 (0.38–1.08) 0.09
Age  duration  pack-years smoked  TCpO2 0.63 (0.37–1.08) 0.09
Multivariate model: age  duration  pack-years
smoked  height  ABPI 0.85  TCpO2 0.70 (0.40–1.21) 0.2
Autonomic nerve function (heart rate decline in response to deep breathing, bpm) by
ethnicity
Adjustment factors
Odds ratio (95% CI)
P value* Indian Asian European
Unadjusted 10.8 (9.8–11.8) 8.5 (7.5–9.5) 0.002
Age  diabetes duration 10.8 (9.8–11.7) 8.7 (7.8–9.6) 0.003
Age  duration  height 10.9 (9.9–11.8) 8.6 (7.7–9.6) 0.002
Age  duration  weight 10.4 (9.4,11.4) 9.0 (8.0–10.0) 0.07
Age  duration  BMI 10.4 (9.4–11.3) 9.1 (8.1–10.0) 0.08
*P value for ethnic difference.
Abbott and Associates
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